Konicef TZ 250mg/31.25mg Injection
Marketer
Kanraxy Pharma
Salt Composition
Ceftriaxone (250mg) + Tazobactum (31.25mg)
Overview Konicef TZ 250mg/31.25mg Injection
Cefixime and Sulbactam injection (250mg/31.25mg), marketed as Konicef TZ, combats diverse bacterial infections. This dual-action medication inhibits microbial proliferation, curbing infection spread. Administration must be strictly under medical guidance; adherence to the prescribed dosage schedule is vital. Complete the entire course, even with symptom improvement; premature cessation may reduce efficacy. Potential side effects include nausea, vomiting, diarrhea, and digestive upset. Severe or persistent side effects warrant immediate medical attention. Allergic reactions (rash, itching, swelling, breathing difficulties) necessitate immediate emergency care. Inform your physician of all current medications, especially if pregnant or breastfeeding, before commencing treatment. Alcohol consumption should be avoided due to potential increased drowsiness. While usually non-impairing, refrain from driving if experiencing drowsiness or dizziness. Adequate rest, nutrition, and hydration contribute to faster recovery. Your doctor may order tests to monitor the treatment's impact.
Uses of Konicef TZ 250mg/31.25mg Injection
Infections caused by bacteria
Major Benefits of Konicef TZ 250mg/31.25mg Injection:
Administering this medication will be performed by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Konicef TZ 250mg/31.25mg Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Konicef TZ 250mg/31.25mg Injection:
Administering this medication will be performed by your healthcare provider. Self-medication is strictly prohibited.
How Konicef TZ 250mg/31.25mg Injection works:
Ceftriaxone/Tazobactum injection (Konicef TZ 250mg/31.25mg) combines a cephalosporin antibiotic, Ceftriaxone, with the beta-lactamase inhibitor, Tazobactum. Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, hindering their growth and survival. Tazobactum counteracts bacterial resistance mechanisms, thereby improving Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse interactions between Konicef TZ 250mg/31.25mg Injection and alcohol consumption.
PregnancySAFE IF PRESCRIBED
Injections of Konicef TZ 250mg/31.25mg are typically deemed safe for use during pregnancy. Preclinical trials using animals revealed minimal or no negative impacts on fetal development; nevertheless, data from human trials remains scarce.
Breast feedingCAUTION
Administering Konicef TZ 250mg/31.25mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's course of treatment and until the medication is fully cleared from her system.
DrivingUNSAFE
Administering Konicef TZ 250mg/31.25mg Injection may induce drowsiness, blurred vision, or dizziness. Refrain from operating a vehicle should these effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Konicef TZ 250mg/31.25mg Injection to individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
The injectable medication, Konicef TZ 250mg/31.25mg, requires careful administration in individuals with significant hepatic impairment. Dosage modification might be necessary; physician consultation is advised. Altering the dose of Konicef TZ 250mg/31.25mg Injection is not suggested for patients experiencing mild or moderately compromised liver function.
What if you forget to take Konicef TZ 250mg/31.25mg Injection :
Omit a Konicef TZ 250mg/31.25mg Injection dose? Seek your physician's advice.
Facts to Know About Konicef TZ 250mg/31.25mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Anti-Infectives |
3,018 People bought this recently